Boltz-1 is an AI model developed by Massachusetts Institute of Technology (MIT) and Genesis Therapeutics (United States), first published in November 2024. It works in the biology domain, on tasks such as protein folding prediction, protein-ligand contact prediction, protein interaction prediction and protein structure comparison.
Epoch AI has no training-compute estimate for this model.
Access: Open weights (unrestricted). Its weights are openly available. Epoch AI rates the confidence of this record as likely.